熱門資訊> 正文

Atea Pharmaceuticals宣布股票回购计划

2025-04-17 20:07

Atea Pharmaceuticals(AVIR) 0

Atea Pharmaceuticals (NASDAQ:AVIR) announced on Thursday the appointment of Howard H. Berman to its board.
Atea also announced that its board has authorized, and will promptly begin executing upon, the repurchase of up to $25M of the company’s common stock.
Atea Pharmaceuticals (NASDAQ:AVIR) shares were up more than 3% in premarket trading.

More on Atea Pharmaceuticals

Atea Pharmaceuticals, Inc. (AVIR) Q4 2024 Earnings Call Transcript
Atea Pharmaceuticals, Inc. 2024 Q4 - Results - Earnings Call Presentation
Seeking Alpha’s Quant Rating on Atea Pharmaceuticals
Historical earnings data for Atea Pharmaceuticals
Financial information for Atea Pharmaceuticals

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。